Autoantibodies to Joint-Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals - Top-Institutions - MDSpire

Association of Autoantibodies to Joint-Related Peptides with the Development of Rheumatoid Arthritis in Asymptomatic Seronegative Patients

  • By

  • Outi Sareila

  • Linda Johansson

  • Anders Lundquist

  • Monica Leu Agelii

  • Lei Cheng

  • Yibo He

  • Erik Lönnblom

  • Maria Andersson

  • Jan Kihlberg

  • Anders Esberg

  • Inger Gjertsson

  • Rikard Holmdahl

  • Solbritt Rantapää-Dahlqvist

  • May 27, 2026

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Department of Rheumatology, Umeå
    Department of Rheumatology, Umeå

    Umeå, Västerbotten

    Key Differentiators

    • Rheumatology

  • #2

    Medical Biobank of northern Sweden
    Medical Biobank of northern Sweden

    Umeå, Västerbotten

    Key Differentiators

    • Rheumatology

  • #3

    Halland OA cohort (HALLOA)
    Halland OA cohort (HALLOA)

    Halmstad, Halland

    Key Differentiators

    • Rheumatology

  • #4

    Leiden Early Arthritis Cohort
    Leiden Early Arthritis Cohort

    Leiden, South Holland

    Key Differentiators

    • Rheumatology

  • #5

    Institute of Rheumatology at Tokyo Women’s Medical University
    Institute of Rheumatology at Tokyo Women’s Medical University

    Tokyo, Tokyo

    Key Differentiators

    • Rheumatology

Original Source(s)

Autoantibodies to Joint-Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals

  • by Outi Sareila, Linda Johansson, Anders Lundquist, Monica Leu Agelii, Lei Cheng, Yibo He, Erik Lönnblom, Maria Andersson, Jan Kihlberg, Anders Esberg, Inger Gjertsson, Rikard Holmdahl, Solbritt Rantapää-Dahlqvist

  • May 27, 2026

Related Content

Rice body synovitis of the shoulder joint: a case report and review of clinical management and pathology

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

Rheumatoid Arthritis and Coronary Artery Calcium Progression: A Case Cohort Analysis From ELSA-Brasil